T Furuta

1.0k total citations
16 papers, 880 citations indexed

About

T Furuta is a scholar working on Molecular Biology, Oncology and Toxicology. According to data from OpenAlex, T Furuta has authored 16 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 4 papers in Toxicology. Recurrent topics in T Furuta's work include Cancer therapeutics and mechanisms (13 papers), Cancer Treatment and Pharmacology (7 papers) and Bioactive Compounds and Antitumor Agents (4 papers). T Furuta is often cited by papers focused on Cancer therapeutics and mechanisms (13 papers), Cancer Treatment and Pharmacology (7 papers) and Bioactive Compounds and Antitumor Agents (4 papers). T Furuta collaborates with scholars based in Japan. T Furuta's co-authors include Teruo Yokokura, T Yokokura, Hiroko Nagata, N Kaneda, K Nokata, Ritsuo Aiyama, Sadao Sawada, Masashi Aonuma, Kensuke Matsumoto and Kentaro Yamaguchi and has published in prestigious journals such as Molecular Cancer Therapeutics, Biological and Pharmaceutical Bulletin and Cancer Chemotherapy and Pharmacology.

In The Last Decade

T Furuta

16 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T Furuta Japan 10 746 497 216 180 97 16 880
Yasuyoshi Kawato Japan 9 830 1.1× 647 1.3× 149 0.7× 129 0.7× 113 1.2× 11 1.1k
Allan W. Nicholas United States 11 1.3k 1.8× 758 1.5× 384 1.8× 235 1.3× 195 2.0× 15 1.5k
Ellen Friche Denmark 16 500 0.7× 496 1.0× 71 0.3× 61 0.3× 37 0.4× 28 733
Katsushige Gomi Japan 19 732 1.0× 408 0.8× 173 0.8× 381 2.1× 192 2.0× 52 1.2k
Marie‐Christine Haaz France 10 572 0.8× 522 1.1× 42 0.2× 46 0.3× 98 1.0× 12 732
E Gupta United States 12 779 1.0× 661 1.3× 40 0.2× 30 0.2× 103 1.1× 15 1.0k
Ikuo Mitsui Japan 11 311 0.4× 231 0.5× 59 0.3× 189 1.1× 51 0.5× 17 517
Bulbul Pandit United States 18 594 0.8× 299 0.6× 55 0.3× 276 1.5× 97 1.0× 26 972
Lars H. Jensen Denmark 16 600 0.8× 240 0.5× 105 0.5× 87 0.5× 39 0.4× 25 721
Chantal Etiévant France 18 596 0.8× 341 0.7× 70 0.3× 129 0.7× 23 0.2× 34 872

Countries citing papers authored by T Furuta

Since Specialization
Citations

This map shows the geographic impact of T Furuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Furuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Furuta more than expected).

Fields of papers citing papers by T Furuta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Furuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Furuta. The network helps show where T Furuta may publish in the future.

Co-authorship network of co-authors of T Furuta

This figure shows the co-authorship network connecting the top 25 collaborators of T Furuta. A scholar is included among the top collaborators of T Furuta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Furuta. T Furuta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yamazaki, Ryuta, T Furuta, Koji Hatano, et al.. (2011). Novel Acrylonitrile Derivatives, YHO-13177 and YHO-13351, Reverse BCRP/ABCG2-Mediated Drug ResistanceIn VitroandIn Vivo. Molecular Cancer Therapeutics. 10(7). 1252–1263. 38 indexed citations
2.
Shishido, Yoshiyuki, T Furuta, Takeshi Matsuzaki, Hiroshi Nagata, & Shusuke Hashimoto. (2010). Efficacy of Combination Treatment and Influence of Schedule with Irinotecan and Amrubicin in Human Lung Carcinoma Cells in Vivo and in Vitro. Biological and Pharmaceutical Bulletin. 33(7). 1183–1191. 1 indexed citations
3.
4.
Takagi, Akimitsu, et al.. (2006). 156 POSTER Antitumor activity of IHL-305, a novel PEGylated liposome containing irinotecan, in huan xenograft models. European Journal of Cancer Supplements. 4(12). 50–50. 1 indexed citations
5.
Yaegashi, Takashi, Sadao Sawada, Hiroshi Nagata, et al.. (1994). Synthesis and Antitumor Activity of 20(S)-Camptothecin Derivatives. A-Ring-Substituted 7-Ethylcamptothecins and Their E-Rig-Modified Water-Soluble Derivatives.. Chemical and Pharmaceutical Bulletin. 42(12). 2518–2525. 39 indexed citations
6.
Yaegashi, Takashi, Seiji Sawada, T Furuta, et al.. (1993). Chemical Modification of Antitumor Alkaloids, 20(S)-Camptothecin and 7-Ethylcamptothecin: Reaction of the E-Lactone Ring Portion with Hydrazine Hydrate.. Chemical and Pharmaceutical Bulletin. 41(5). 971–974. 9 indexed citations
7.
Sawada, Sadao, Takashi Yaegashi, T Furuta, T Yokokura, & Tsutomu Miyasaka. (1993). Chemical Modification of an Antitumor Alkaloid, 20(S)-Camptothecin. E-Lactone Ring-Modified Water-Soluble Derivatives of 7-Ethylcamptothecin.. Chemical and Pharmaceutical Bulletin. 41(2). 310–313. 19 indexed citations
8.
Yaegashi, Takashi, K Nokata, Seiji Sawada, et al.. (1992). Chemical Modification of an Antitumor Alkaloid, 20(S)-Camptothecin: Glycosides, Phosphates and Sulfates of 7-Ethyl-10-hydroxycamptothecin.. Chemical and Pharmaceutical Bulletin. 40(1). 131–135. 9 indexed citations
9.
Kawato, Yasuyoshi, T Furuta, Masashi Aonuma, et al.. (1991). Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice. Cancer Chemotherapy and Pharmacology. 28(3). 192–198. 137 indexed citations
10.
Sawada, Seigo, Satoru Okajima, Ritsuo Aiyama, et al.. (1991). Synthesis and Antitumor Activity of 20(S)-Camptothecin Derivatives: Carbamate-Linked, Water-Soluble Derivatives of 7-Ethyl-10-hydroxycamptothecin.. Chemical and Pharmaceutical Bulletin. 39(6). 1446–1454. 193 indexed citations
11.
Sawada, Seiji, Satoshi Matsuoka, K Nokata, et al.. (1991). Synthesis and Antitumor Activity of 20(S)-Camptothecin Derivatives: A-Ring Modified and 7,10-Disubstituted Camptothecins.. Chemical and Pharmaceutical Bulletin. 39(12). 3183–3188. 58 indexed citations
12.
Sawada, Sadao, K Nokata, T Furuta, Teruo Yokokura, & TSUYOSHI MIYASAKA. (1991). Chemical Modification of an Antitumor Alkaloid Camptothecin: Synthesis and Antitumor Activity of 7-C-Substituted Camptothecins.. Chemical and Pharmaceutical Bulletin. 39(10). 2574–2580. 64 indexed citations
13.
Furuta, T & Teruo Yokokura. (1991). [Combination therapy of CPT-11, a camptothecin derivative, with various antitumor drugs against L 1210 leukemia].. PubMed. 18(3). 393–402. 8 indexed citations
14.
Furuta, T & Teruo Yokokura. (1990). [Effect of administration schedules on the antitumor activity of CPT-11, a camptothecin derivative].. PubMed. 17(1). 121–30. 20 indexed citations
15.
Kaneda, N, Hiroko Nagata, T Furuta, & T Yokokura. (1990). Metabolism and pharmacokinetics of the camptothecin analogue CPT-11 in the mouse.. PubMed. 50(6). 1715–20. 266 indexed citations
16.
Furuta, T, Teruo Yokokura, & Masahiko Mutai. (1988). [Antitumor activity of CPT-11 against rat Walker 256 carcinoma].. PubMed. 15(9). 2757–60. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasuyoshi Kawato Breakdown of academic impact, for papers by Allan W. Nicholas Breakdown of academic impact, for papers by Ellen Friche Breakdown of academic impact, for papers by Katsushige Gomi Breakdown of academic impact, for papers by Marie‐Christine Haaz Breakdown of academic impact, for papers by E Gupta Breakdown of academic impact, for papers by Ikuo Mitsui Breakdown of academic impact, for papers by Bulbul Pandit Breakdown of academic impact, for papers by Lars H. Jensen Breakdown of academic impact, for papers by Chantal Etiévant
Rankless by CCL
2026